ETC

Recommend
Index
  • Calcort Tab. 6mg

    Calcort Tab. 6mg

    Ingredient

    Deflazacort (Micronized)

    Content

    6mg

    Indication

    1) rheumatoid disorders and connective tissue diseases: Maintenance therapy and treatment of acute exacerbation of psoriatic arthritis and rheumatoid arthritis, which are ineffective with general treatment, polymyalgia rheumatic, acute rheumatic fever, systemic lupus erythematosus, cranial arteritis, and Wegener’s granulomatosis
    2) skin diseases: Pemphigus, bullous pemphigoid, exfoliative dermatitis, erythema multiforme, erythema nodosum, and severe psoriasis
    3) allergic diseases: Bronchial asthma, which is not effective with general treatment
    4) respiratory diseases: Sarcoidosis with pulmonary infiltration, extrinsic allergic alveolitis (silicosis due to organic dust), desquamative interstitial pneumonia (idiopathic pulmonary fibrosis)
    5) ophthalmic diseases: Choroiditis, chorioretinitis, iritis, and iridocyciltis
    6) hematopoietic system diseases: Idiopathic thrombocytopenia, hemolytic anemia, lymphatic leukemia, and lymphoma
    7) gastrointestinal diseases: Ulcerative colitis and Crohn’s disease
    8) liver disease: Chronic active hepatitis (autoimmune hepatitis)
    9) kidney disease: Nephrotic syndrome

  • Celex

    Celex

    Ingredient

    Celecoxib

    Content

    200mg

    Indication

    Celecoxib is indicated in adults for the symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.

  • Cleocin-T Topical soln. 1%

    Cleocin-T Topical soln. 1%

    Ingredient

    Clindamycin Phosphate

    Content

    1.188g/100ml (1g as Clindamycin)

    Indication

    Effective species: Propionibacterium acnes
    Indication: Treatment of acne vulgaris

  • Coaprovel®Tablet 150/12.5mg, 300/12.5mg

    Coaprovel®Tablet 150/12.5mg, 300/12.5mg

    Ingredient

    [Coaprovel®Tablet 150/12.5mg]
    Hydrocholorothiazide 12.5mg
    Irbesartan 150mg

     

    [Coaprovel®Tablet 300/12.5mg]
    Hydrocholorothiazide 12.5mg
    Irbesartan 300mg

    Content

    [Coaprovel®Tablet 150/12.5mg]
    Oval film-coated tablet with a convex shape on both sides with pink color. One side is engraved with a heart shape, and the other side is marked with the number “2875”

    [Coaprovel®Tablet 300/12.5mg]
    Oval film-coated tablet with a convex shape on both sides with pink color. One side is engraved with a heart shape, and the other side is marked with the number “2876”

    Indication

    Essential hypertension
    1. Patients not adequately controlled with monotherapy for hypertension
    2. Initial therapy for patients, including those with moderate to severe hypertension (Stage 2), requiring combination therapy to achieve target blood pressure

TOP